North America Diabetic Assays Market - Industry Trends and Forecast To 2027

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF NORTH AMERICA DIABETIC ASSAYS MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRODUCTS LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.10 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.1.1 INCREASING PREVALENCE OF DIABETES

3.1.2 INCREASING GERIATRIC POPULATION

3.1.3 TECHNOLOGICAL ADVANCEMENT

3.1.4 AVAILABILITY OF REIMBURSEMENT

3.1.5 INCREASING DEMAND FOR THE HAND-HELD DIAGNOSTIC DEVICES

3.2 RESTRAINT

3.2.1 PRODUCT RECALL

3.2.2 HIGH COST OF THE ASSAY

3.2.3 IMPLEMENTATION OF EXCISE DUTY BY THE U.S. GOVERNMENT

3.3 OPPORTUNITIES

3.3.1 RISING GOVERNMENT INITIATIVES

3.3.2 STRATEGIC INITIATIVE BY MARKET PLAYERS

3.3.3 RISE IN AWARENESS AMONG THE POPULATION

3.3.4 GROWING HEALTHCARE INFRASTRUCTURE

3.4 CHALLENGES

3.4.1 STRINGENT REGULATION

3.4.2 LACK OF SKILLED PROFESSIONALS

3.4.3 LOW PENETRATION IN DEVELOPING ECONOMIES

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 REGULATORY PROCEDURE

7 NORTH AMERICA DIABETIC ASSAYS MARKET, BY TYPE

7.1 OVERVIEW

7.2 ASSAYS

7.2.1 DIABETES DIAGNOSTICS GLUCOSE ASSAY

7.2.2 DIABETES DIAGNOSTICS HBA1C ASSAY

7.3 DEVICES

7.3.1 ANALYZERS

7.3.2 SOFTWARE

7.4 CONSUMABLES

7.4.1 TEST STRIPS

7.4.2 REAGENT

7.4.3 OTHERS

8 NORTH AMERICA DIABETIC ASSAYS MARKET, BY DISEASE TYPE

8.1 OVERVIEW

8.2 TYPE 2 DIABETES

8.3 TYPE 1 DIABETES

8.4 GESTATIONAL DIABETES

9 NORTH AMERICA DIABETIC ASSAYS MARKET, BY DEPLOYMENT

9.1 OVERVIEW

9.2 AUTOMATED

9.3 MANUAL

10 NORTH AMERICA DIABETIC ASSAYS MARKET, BY END USER

10.1 OVERVIEW

10.2 HOSPITALS

10.3 DIAGNOSTIC LABORATORIES

10.4 CLINICS

10.5 ACADEMIC INSTITUTES

10.6 OTHERS

11 NORTH AMERICA DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL

11.1 OVERVIEW

11.2 DIRECT

11.3 INDIRECT

12 NORTH AMERICA DIABETIC ASSAYS MARKET, BY GEOGRAPHY

12.1 NORTH AMERICA

12.1.1 U.S.

12.1.2 CANADA

12.1.3 MEXICO

13 NORTH AMERICA DIABETIC ASSAYS MARKET, COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

14 COMPANY PROFILE

14.1 BIO-RAD LABORATORIES, INC.

14.1.1 COMPANY SNAPSHOT

14.1.2 REVENUE ANALYSIS

14.1.3 COMPANY SHARE ANALYSIS

14.1.4 PRODUCT PORTFOLIO

14.1.5 RECENT DEVELOPMENT

14.2 ABBOTT

14.2.1 COMPANY SNAPSHOT

14.2.2 REVENUE ANALYSIS

14.2.3 COMPANY SHARE ANALYSIS

14.2.4 PRODUCT PORTFOLIO

14.2.5 RECENT DEVELOPMENT

14.3 SIEMENS HEALTHINEERS AG

14.3.1 COMPANY SNAPSHOT

14.3.2 REVENUE ANALYSIS

14.3.3 COMPANY SHARE ANALYSIS

14.3.4 PRODUCT PORTFOLIO

14.3.5 RECENT DEVELOPMENT

14.4 DANAHER

14.4.1 COMPANY SNAPSHOT

14.4.2 REVENUE ANALYSIS

14.4.3 COMPANY SHARE ANALYSIS

14.4.4 PRODUCT PORTFOLIO

14.4.5 RECENT DEVELOPMENT

14.5 DIASORIN S.P.A.

14.5.1 COMPANY SNAPSHOT

14.5.2 REVENUE ANALYSIS

14.5.3 COMPANY SHARE ANALYSIS

14.5.4 PRODUCT PORTFOLIO

14.5.5 RECENT DEVELOPMENT

14.6 ABNOVA CORPORATION

14.6.1 COMPANY SNAPSHOT

14.6.2 PRODUCT PORTFOLIO

14.6.3 RECENT DEVELOPMENT

14.7 ALPCO

14.7.1 COMPANY SNAPSHOT

14.7.2 PRODUCT PORTFOLIO

14.7.3 RECENT DEVELOPMENTS

14.8 BIOASSAY SYSTEMS

14.8.1 COMPANY SNAPSHOT

14.8.2 PRODUCT PORTFOLIO

14.8.3 RECENT DEVELOPMENT

14.9 DIAGNOSTIC AUTOMATION/CORTEZ DIAGNOSTICS INC.

14.9.1 COMPANY SNAPSHOT

14.9.2 PRODUCT PORTFOLIO

14.9.3 RECENT DEVELOPMENT

14.10 DIAZYME LABORATORIES, INC.

14.10.1 COMPANY SNAPSHOT

14.10.2 PRODUCT PORTFOLIO

14.10.3 RECENT DEVELOPMENTS

14.11 DRG INSTRUMENTS GMBH

14.11.1 COMPANY SNAPSHOT

14.11.2 PRODUCT PORTFOLIO

14.11.3 RECENT DEVELOPMENT

14.12 EKF DIAGNOSTICS HOLDINGS PLC

14.12.1 COMPANY SNAPSHOT

14.12.2 REVENUE ANALYSIS

14.12.3 PRODUCT PORTFOLIO

14.12.4 RECENT DEVELOPMENT

14.13 ETHOS BIOSCIENCES, INC.

14.13.1 COMPANY SNAPSHOT

14.13.2 PRODUCT PORTFOLIO

14.13.3 RECENT DEVELOPMENT

14.14 MEDIPAN GMBH

14.14.1 COMPANY SNAPSHOT

14.14.2 PRODUCT PORTFOLIO

14.14.3 RECENT DEVELOPMENT

14.15 MERCK KGAA

14.15.1 COMPANY SNAPSHOT

14.15.2 REVENUE ANALYSIS

14.15.3 PRODUCT PORTFOLIO

14.15.4 RECENT DEVELOPMENT

14.16 MONOBIND INC.

14.16.1 COMPANY SNAPSHOT

14.16.2 PRODUCT PORTFOLIO

14.16.3 RECENT DEVELOPMENT

14.17 ORGENTEC DIAGNOSTIKA GMBH

14.17.1 COMPANY SNAPSHOT

14.17.2 PRODUCT PORTFOLIO

14.17.3 RECENT DEVELOPMENT

14.18 ORTHO CLINICAL DIAGNOSTICS

14.18.1 COMPANY SNAPSHOT

14.18.2 PRODUCT PORTFOLIO

14.18.3 RECENT DEVELOPMENT

14.19 PTS DIAGNOSTICS (A SUBSIDIARY OF SANNUO BIOSENSOR CO., LTD.)

14.19.1 COMPANY SNAPSHOT

14.19.2 PRODUCT PORTFOLIO

14.19.3 RECENT DEVELOPMENT

14.20 TOSOH CORPORATION

14.20.1 COMPANY SNAPSHOT

14.20.2 REVENUE ANALYSIS

14.20.3 PRODUCT PORTFOLIO

14.20.4 RECENT DEVELOPMENT

15 QUESTIONNAIRE

16 RELATED REPORTS

TABLE 1 CANADA REIMBURSEMENT LIMITS FOR TEST STRIPS FOR EACH 365-DAY PERIOD

TABLE 2 IRELAND REIMBURSEMENT FOR TEST STRIPS

TABLE 3 COMPARISON OF NGSP-CERTIFIED A1C POC DEVICES

TABLE 4 MEDICAL DEVICE RECALLS

TABLE 5 BIO-RAD LABORATORIES, INC. (U.S.) DIABETIC ASSAYS PRICES

TABLE 6 PRIVATE-SECTOR R&D INVESTMENT IN MEDICAL DEVICES AND EQUIPMENT ( IN USD MILLION)

TABLE 7 HEALTHCARE EXPENDITURE IN ASIA-PACIFIC

TABLE 8 DIRECT COSTS OF DIABETES (IN USD)

TABLE 9 NORTH AMERICA DIABETIC ASSAYS MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 10 NORTH AMERICA ASSAYS DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 11 NORTH AMERICA ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 12 NORTH AMERICA DEVICES IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 13 NORTH AMERICA DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 14 NORTH AMERICA CONSUMABLES IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 15 NORTH AMERICA CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 16 NORTH AMERICA DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)

TABLE 17 NORTH AMERICA TYPE 2 DIABETES DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 18 NORTH AMERICA TYPE 1 DIABETES IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 19 NORTH AMERICA GESTATIONAL DIABETES IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 20 NORTH AMERICA DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)

TABLE 21 NORTH AMERICA AUTOMATED IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 22 NORTH AMERICA MANUAL IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 23 NORTH AMERICA DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 24 NORTH AMERICA HOSPITALS IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 25 NORTH AMERICA DIAGNOSTIC LABORATORIES IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 26 NORTH AMERICA CLINICS IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 27 NORTH AMERICA ACADEMIC INSTITUTES IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 28 NORTH AMERICA OTHERS IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 29 NORTH AMERICA DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 30 NORTH AMERICA DIRECT IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 31 NORTH AMERICA INDIRECT IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 32 NORTH AMERICA DIABETIC ASSAYS MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 33 NORTH AMERICA DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 34 NORTH AMERICA DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 35 NORTH AMERICA ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 36 NORTH AMERICA CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 37 NORTH AMERICA DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)

TABLE 38 NORTH AMERICA DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)

TABLE 39 NORTH AMERICA DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 40 NORTH AMERICA DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 41 U.S. DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 42 U.S. DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 43 U.S. ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 44 U.S. CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 45 U.S. DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)

TABLE 46 U.S. DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)

TABLE 47 U.S. DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 48 U.S. DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 49 CANADA DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 50 CANADA DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 51 CANADA ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 52 CANADA CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 53 CANADA DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)

TABLE 54 CANADA DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)

TABLE 55 CANADA DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 56 CANADA DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 57 MEXICO DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 58 MEXICO DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 59 MEXICO ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 60 MEXICO CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 61 MEXICO DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)

TABLE 62 MEXICO DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)

TABLE 63 MEXICO DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 64 MEXICO DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)